A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.
Quantabio has launched the sparQ™ Lysis Kit, designed to isolate high-quality, double-stranded genomic DNA from dried blood spot (DBS) samples.
Founded by Dr. Thomas Crisman, Genome Based Diagnostics has focused on developing accessible and reliable testing solutions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback